The extremely rare condition of molar pregnancy with a coexisting fetus progressing to a viable infant, is reported. At 20 weeks gestational age, prenatal diagnosis was made by biochemical and sonographic findings, in which elevated free beta-human chorionic gonadotrophin (HCG, 500 ng/ml) was noted and ultrasound showed a well-defined multicystic snowstorm-like mass connecting with placenta. Ch...

OBJECTIVE A twin pregnancy consisting of a complete hydatidiform mole with a coexisting normal fetus is extremely rare with an incidence of 1/22,000 to 1/100,000. The incidence of preterm delivery is high and few pregnancies reach near term with a viable fetus. CASE REPORT A 34-year-old woman presented at 20 weeks of gestation with increased levels of serum beta human chorionic gonadotropin (...

Background: Placental mesenchymal dysplasia (PMD) is a distinct syndrome of unknown aetiology that associated with significant fetal morbidity and mortality. Intrauterine growth restriction common, yet, paradoxically, many the fetuses/newborns have been diagnosed Beckwith-Wiedemann (BWS). Methods: We report two cases PMD high levels androgenetic (complete paternal uniparental isod...

Development of the respiratory system begins at 3 weeks gestation, and aberrations in the developmental processes may give rise to a group of structural abnormalities collectively referred to as bronchopulmonary foregut malformations (BPFMs). The common BPFMs include congenital cystic adenomatoid malformation (CCAM), pulmonary sequestration, congenital lobar emphysema, and bronchogenic cysts (B...

In the United States, molar pregnancy occurs between 1 in 1,200 and 1 in 2,500 pregnancies. The critical nature of complications associated with a molar pregnancy requires advanced perioperative anesthetic management. This case report details the perioperative events of a 34-year-old gravida 5, para 3, with a partial molar pregnancy who underwent general anesthesia for a dilatation and curettag...

Partial hydatidiform mole and coexisting fetus (PHMCF) is a rare condition that presents a dilemma for physicians and the parents of the fetus, particularly when PHMCF is detected during the second trimester of pregnancy. The present study reports a case of PHMCF terminated by induction of labor via administration of Rivanol at 17 weeks. Follow-up measurements of serum β-human chorionic gonadot...